HERON THERAPEUTICS, INC. /DE/ (HRTX) Operating Lease, Liability, Noncurrent USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Heron Therapeutics, Inc. /De/ quarterly Operating Lease, Liability, Noncurrent history and growth rate from 2019 to 2024.
  • Heron Therapeutics, Inc. /De/ Operating Lease, Liability, Noncurrent for the quarter ending March 31, 2024 was $2.05 M, a 57.7% decline year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $2.05 M -$2.79 M -57.7% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $2.8 M -$2.7 M -49.1% Dec 31, 2023 10-Q 2024-05-07
Q3 2023 $3.54 M -$2.61 M -42.5% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $4.16 M -$2.62 M -38.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $4.83 M -$2.56 M -34.6% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $5.5 M -$2.5 M -31.2% Dec 31, 2022 10-K 2024-03-12
Q3 2022 $6.15 M -$6.07 M -49.7% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $6.78 M -$6.23 M -47.9% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $7.39 M -$6.4 M -46.4% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $8 M -$6.57 M -45.1% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $12.2 M -$3.08 M -20.1% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $13 M -$3 M -18.7% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $13.8 M -$2.92 M -17.5% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $14.6 M +$2.32 M +18.9% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $15.3 M +$4.52 M +41.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $16 M +$4.76 M +42.3% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $16.7 M +$4.99 M +42.5% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $12.2 M Dec 31, 2019 10-K 2021-02-24
Q3 2019 $10.8 M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $11.3 M Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $11.7 M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.